David C. Davis
Keine laufenden Positionen mehr
Profil
David C.
Davis worked as a Biologist at EIDP, Inc. from 1986 to 2001.
He also worked as Vice President-Manufacturing at Chesapeake PERL, Inc. Mr. Davis holds an MBA from Goldey-Beacom College and an undergraduate degree from the University of Delaware.
Ehemalige bekannte Positionen von David C. Davis
| Unternehmen | Position | Ende |
|---|---|---|
| E I DU PONT DE NEMOURS AND CO | Corporate Officer/Principal | 01.01.2001 |
Chesapeake PERL, Inc.
 Chesapeake PERL, Inc. BiotechnologyHealth Technology Chesapeake PERL, Inc. operates as a biotechnology company which develops and produces proteins. Its proprietary technology - PERLXPRess, which uses insect larvae allows manufacturing without expensive process development for scale-up. The firm also produces humanized glycoproteins and human therapeutics, including kinases, viral antigens and antibodies. The company was founded by Terry E. Chase, Minh Q. Pham and William E. Bentley in 1998 and is headquartered in Savage, MD. | Corporate Officer/Principal | - |
Ausbildung von David C. Davis
| Goldey-Beacom College | Masters Business Admin |
| University of Delaware | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Chesapeake PERL, Inc.
Chesapeake PERL, Inc. BiotechnologyHealth Technology Chesapeake PERL, Inc. operates as a biotechnology company which develops and produces proteins. Its proprietary technology - PERLXPRess, which uses insect larvae allows manufacturing without expensive process development for scale-up. The firm also produces humanized glycoproteins and human therapeutics, including kinases, viral antigens and antibodies. The company was founded by Terry E. Chase, Minh Q. Pham and William E. Bentley in 1998 and is headquartered in Savage, MD. | Health Technology |